MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • MDS Clinical Supportive Criteria for Parkinson’s Disease are Associated with α-Synuclein Seed Amplification Assay Status

    D. Belete, E. Mitchell, N. Donkor, A. Noyce, C. Simonet (London, United Kingdom)

  • MDS PD e-Diary – a New Patient-Centered Digital Tool for People with Parkinson’s Disease

    P. Rábano-Suárez, MHG. Monje, JA. Vizcarra, SS. Paul, S. Avión, M. Morse, M. Skorvanek, MHS. Tosin, R. Fuller, TH. Turner, M. Dekker, DA. Hall, K. Bergmann, J. Cedarbaum, W. Maetzler, AJ. Espay, P. Martínez-Martín, GT. Stebbins, T. Mestre, A. Sánchez-Ferro (Madrid, Spain)

  • MDSGene Update and Expansion: Clinical and Genetic Spectrum of LRRK2 Variants in Parkinson´s Disease

    C. Krüger, S-Y. Lim, A. Buhrmann, FL. Fahrig, C. Gabbert, N. Bahr, H. Madoev, C. Marras, C. Klein, K. Lohmann (Luebeck, Germany)

  • Measures of Mitochondrial Function in Serum across the Parkinson’s Disease Spectrum

    L. Neilson, J. Elliott, M. Lim, N. Gray (Portland, USA)

  • Measuring Cortisol Levels in Persons with Huntington’s Disease

    A. Clarke, B. Lobb, A. Hiller (Portland, USA)

  • Measuring Motor Improvement with a Wearable Device in a Parkinson Disease Patient undergoing Subcutaneous Levodopa Carbidopa Infusion

    N. Lopez Ariztegui, MI. Morales Casado, G. Tabar Comellas (TOLEDO, Spain)

  • Mechanical and thermal thresholds in the MPTP macaque model of Parkinson’s disease

    A. Sadoun, Q. Li, E. Pioli, T. Dhellemmes, M. Landry, E. Bezard (Floirac, France)

  • Mechanism Study of Familial Cortical Myoclonic Tremor with Epilepsy Type 1 Caused by Pentanucleotide Repeat Expansion in the SAMD12 Gene

    Z-D. Cen, F. Zhang, Y-L. Chen, X-H. Chen, W. Luo (Hangzhou, China)

  • Medication Effects on Bradykinesia and Tremor in Parkinson’s Disease, Measured by Wearable Sensors

    R. Weijer, A. Szanto, V. Exadaktylos, J. van Hilten, D. Hepp (Leiden, Netherlands)

  • Medication Refractory Restless Legs Syndrome: Real-World Experience

    P. Petramfar, J. Jankovic (Houston, USA)

  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley